Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes Than with Either Monotherapy in Patients with Early Rheumatoid Arthritis: 8-Year Results of An Open-Label Extension of a Phase 3 Trial

被引：0

作者：

Breedveld, Ferdinand C. ^{[1
]}

Keystone, Edward ^{[2
]}

van der Heijde, Desiree ^{[1
]}

Landewe, Robert ^{[3
]}

Smolen, Josef ^{[4
,5
]}

Guerette, Benoit ^{[6
]}

McIlraith, Melissa ^{[6
]}

Kupper, Hartmut ^{[7
]}

Liu, Shufang ^{[8
]}

Wolfe, Benjamin ^{[8
]}

Kavanaugh, Arthur ^{[9
]}

机构：

[1] Leiden Univ, Med Ctr, Leiden, Netherlands

[2] Univ Toronto, Toronto, ON, Canada

[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[4] Med Univ Vienna, Vienna, Austria

[5] Hietzing Hosp, Vienna, Austria

[6] Abbott, Rungis, France

[7] Abbott GmbH & Co KG, Ludwigshafen, Germany

[8] Abbott, Abbott Pk, IL USA

[9] Univ Calif San Diego, San Diego, CA 92103 USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1231

引用

页码：S481 / S481

页数：1

共 50 条

[1] INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES THAN WITH EITHER MONOTHERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 8-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRIAL
Breedveld, Ferdinand
Keystone, Edward
van der Heijde, Desiree
Landewe, Robert
Smolen, Josef S.
Guerette, Benoit
McIlraith, Melissa
Kupper, Hartmut
Liu, Shufang
Kavanaugh, Arthur
RHEUMATOLOGY, 2012, 51 : 118 - 119
[2] Initial Combination Therapy with Adalimumab Plus Methotrexate Leads to Better Long-Term Outcomes in Patients with Advanced Rheumatoid Arthritis: Analysis of the Final 10-Year Results of An Open-Label Extension of a Phase 3 Trial.
Keystone, Edward
van der Heijde, Desiree
Weinblatt, Michael E.
Mozaffarian, Neelufar
Guerette, Benoit
Kupper, Hartmut
Liu, Shufang
Wolfe, Benjamin
Kavanaugh, Arthur
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S870 - S871
[3] INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES IN PATIENTS WITH ADVANCED RHEUMATOID ARTHRITIS: ANALYSIS OF THE FINAL 10-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRAIL
Keystone, Edward C.
van der Heijde, Desiree
Weinblatt, Michael E.
Mozaffarian, Neelufar
Guerette, Benoit
Kupper, Hartmut
Liu, Shufang
Kavanaugh, Arthur
RHEUMATOLOGY, 2012, 51 : 115 - 115
[4] CLINICAL OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB MONOTHERAPY IN THE OPEN-LABEL LONG-TERM EXTENSION
Fleischmann, R.
Wollenhaupt, J.
Wang, L.
Maniccia, A.
Kwok, K.
Takiya, L.
van Vollenhoven, R.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 259 - 260
[5] Long-Term Impact of Delaying Combination Therapy With Adalimumab Plus Methotrexate By 2 Years in Patients With Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial
Keystone, Edward C.
Breedveld, Ferdinand C.
van der Heijde, Desiree
Landewe, Robert
Florentinus, Stefan
Arulmani, Udayasankar
Liu, Shufang
Kupper, Hartmut
Kavanaugh, Arthur
ARTHRITIS AND RHEUMATISM, 2013, 65 : S595 - S595
[6] LONG-TERM IMPACT OF DELAYING COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE BY 2 YEARS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: FINAL 10-YEAR RESULTS OF THE PREMIER TRIAL
Keystone, E. C.
Breedveld, F. C.
van der Heijde, D.
Landewe, R.
Florentinus, S.
Arulmani, U.
Liu, S.
Kupper, H.
Kavanaugh, A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 227 - 228
[7] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
Burmester, Gerd R.
Fiore, Stefano
Hu, Chih-Chi
Fay, Jonathan
Lee, Eun Bong
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[8] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
Burmester, Gerd
Fiore, Stefano
Hu, Chih-Chi
Fay, Jonathan
Lee, Eun-Bong
Genovese, Mark
JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
[9] Clinical Outcomes for Rheumatoid Arthritis Patients Receiving Tofacitinib Monotherapy in the Open-Label Long-Term Extension over 6 Years
Fleischmann, Roy
Yazici, Yusuf
Wollenhaupt, Juergen
Wang, Lisy
Maniccia, Anna
Kwok, Kenneth
Takiya, Liza
van Vollenhoven, Ronald
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[10] Initial combination therapy with adalimumab and methotrexate leads to better long-term inhibition of radiographic progression in earl RA: 5-year results of the PREMIER trial
van der Heijt, Desiree
Landewe, Robert
Shap, John T.
Keystone, Edward C.
Patra, Kaushik
Perez, John L.
Pangan, Aileen L.
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S535 - S535

← 1 2 3 4 5 →